Patient id, age, gender, weight and ethnicity: patient information were not provided.Sorin group italia manufactures the inspire 6 hollow fiber oxygenator with integrated and hardshell.The incident occurred in (b)(6).The involved device has not been requested for return to sorin group italia for investigation.Through follow-up livanova learned that the event occurred before cross clamp.If any additional information pertinent to the reported event is received, it will be provided in a supplemental report.
|
Verification of manufacturing records confirmed that involved unit was released as conform according to specifications.Review of complaints database revealed no other similar events notified for batch concerned out of (b)(4) total manufactured units, excluding any possible quality defect manufacturing-related.This poor gas exchange condition was identified during a beating-heart surgical phase, prior to applying the aortic cross-clamp.Medical team elected to change out the oxygenator and cpb was initiated and completed without further problems.Based on all the above facts, livanova believes the most likely root cause of reported failure was a multifactorial issue, resulting from the interaction between clinical procedure, patient conditions and initial gas-blood settings.However, presence of shunted area across oxygenating hollow fibers cannot be excluded and/or undesired cellular activation associated with platelet adhesion and fibrin layer deposition inside the oxygenator, biological deposits may coat the fiber bundle capillaries in which the blood flows thus hindering the passage of o2.The above-described contributing factors might have reduced the area to perform gas exchange and a concomitant increase of gas pathway length to perform gas exchange.As no device malfunction could be confirmed, no action is deemed necessary.Livanova will keep monitoring the market.
|